SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed May 19, 2005
Insider Transaction Report
Form 4
Gyenes Lawrence A
SVP, Chief Financial Officer
Transactions
- Purchase
Common Stock, $.01 par value per share
2005-05-17$3.08/sh+9,100$28,028→ 39,600 total - Purchase
Common Stock, $.01 par value per share
2005-05-17$3.06/sh+3,900$11,934→ 43,500 total - Purchase
Common Stock, $.01 par value per share
2005-05-17$3.09/sh+900$2,781→ 44,400 total - Purchase
Common Stock, $.01 par value per share
2005-05-17$3.07/sh+1,100$3,377→ 30,500 total